Rational engineering of recombinant modified vaccinia virus Ankara to enhance both innate and adaptive immunity for cancer immunotherapy

被引：0
|
作者：
Yang, N. [3 ]
Wang, Y. [3 ]
Liu, S. [3 ]
Luna, J. [1 ]
Rossi, A. [3 ]
Mazo, G. [3 ]
Tan, A. [2 ]
Wang, J. [4 ]
Yan, W. [5 ]
Choi, J. [5 ]
Xiang, J. [2 ]
Rice, C. [1 ]
Merghoub, T. [3 ]
Wolchok, J. [3 ]
Deng, L. [3 ]
机构：
[1] Rockefeller Univ, 1230 York Ave, New York, NY 10021 USA
[2] Weill Cornell Med, New York, NY USA
[3] Mem Sloan Kettering Canc Ctr, 1275 York Ave, New York, NY 10021 USA
[4] Genvira Biosci, Ottawa, ON, Canada
[5] IMVAQ Therapeut, Sammamish, WA USA
来源：
JOURNAL OF INVESTIGATIVE DERMATOLOGY | 2021年 / 141卷 / 05期
关键词：
D O I：
暂无
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
697
引用
收藏
页码：S121 / S121
页数：1
相关论文
共 50 条
  • [31] Construction of recombinant modified vaccinia Ankara(MVA) expressing hepatitis B virus surface antigen
    Chen, Y
    Yang, XS
    Yu, XH
    Jiang, CL
    Wu, YG
    Jin, YH
    Chen, Y
    Chen, Y
    Li, W
    Kong, W
    CHEMICAL RESEARCH IN CHINESE UNIVERSITIES, 2006, 22 (02) : 213 - 216
  • [32] Modified vaccinia virus Ankara immunization protects against lethal challenge with recombinant vaccinia virus expressing murine interleukin-4
    McCurdy, LH
    Rutigliano, JA
    Johnson, TR
    Chen, M
    Graham, BS
    JOURNAL OF VIROLOGY, 2004, 78 (22) : 12471 - 12479
  • [33] Immunotherapy of ovarian cancer targeting FSHR by innate and adaptive immunity
    Bordoloi, Devivasha
    Bhojnagarwala, Pratik
    Kulkarni, Abhijeet J.
    Adeniji, Opeyemi S.
    Perales-Puchalt, Alfredo
    O'Connell, Ryan P.
    Zhu, Xizhou
    Parzych, Elizabeth M.
    Zhang, Rugang
    Abdel-Mohsen, Mohamed
    Weiner, David B.
    CANCER RESEARCH, 2022, 82 (12)
  • [34] Recombinant A27 protein synergizes with modified vaccinia Ankara in conferring protection against a lethal vaccinia virus challenge
    He, Yong
    Meseda, Clement A.
    Vassell, Russell A.
    Merchlinsky, Michael
    Weir, Jerry P.
    Weiss, Carol D.
    VACCINE, 2010, 28 (03) : 699 - 706
  • [35] Recombinant modified vaccinia virus Ankara expressing antigen 85A boosts BCG-primed and naturally acquired antimycobacterial immunity in humans
    McShane, H
    Pathan, AA
    Sander, CR
    Keating, SM
    Gilbert, SC
    Huygen, K
    Fletcher, HA
    Hill, AVS
    NATURE MEDICINE, 2004, 10 (11) : 1240 - 1244
  • [36] Recombinant modified vaccinia virus Ankara expressing antigen 85A boosts BCG-primed and naturally acquired antimycobacterial immunity in humans
    Helen McShane
    Ansar A Pathan
    Clare R Sander
    Sheila M Keating
    Sarah C Gilbert
    Kris Huygen
    Helen A Fletcher
    Adrian V S Hill
    Nature Medicine, 2004, 10 : 1240 - 1244
  • [37] Analysis of the Modified Vaccinia Ankara (MVA) - Specific Cellular and Humoral Immunity to a Candidate HIV Recombinant MVA Vaccine
    Muller, T. L.
    Burgers, W. A.
    Chege, G. K.
    Douglass, N.
    Williamson, C.
    Williamson, A.
    AIDS RESEARCH AND HUMAN RETROVIRUSES, 2008, 24 : 141 - 141
  • [38] Evaluation of recombinant modified vaccinia Ankara virus-based rhesus cytomegalovirus vaccines in rhesus macaques
    Yue, Yujuan
    Wang, Zhongde
    Abel, Kristina
    Li, Jinliang
    Strelow, Lisa
    Mandarino, Angelo
    Eberhardt, Meghan K.
    Schmidt, Kimberli A.
    Diamond, Don J.
    Barry, Peter A.
    MEDICAL MICROBIOLOGY AND IMMUNOLOGY, 2008, 197 (02) : 117 - 123
  • [39] Modified vaccinia Ankara encoding both T7 polymerase and a simian immunodeficiency virus genome
    Cholapura-Puttaswamaiah, C. G.
    Blanchard, T. J.
    HIV MEDICINE, 2013, 14 : 27 - 27
  • [40] Highly attenuated modified vaccinia virus Ankara (MVA) as an effective recombinant vector: A murine tumor model
    Carroll, MW
    Overwijk, WW
    Chamberlain, RS
    Rosenberg, SA
    Moss, B
    Restifo, NP
    VACCINE, 1997, 15 (04) : 387 - 394
12345